Condition: Non-Alcoholic Fatty Liver Disease · Non-alcoholic Fatty Liver · Non-alcoholic Steatohepatitis · Sponsor: Cambridge University Hospitals NHS Foundation Trust
The EU-PNAFLD (The European Paediatric NALFD Registry) will be a network composed of European centres involved in the care of children with NAFLD, and will include Hepatologists, Endocrinologists, and Scientists, supported by relevant international specialists. This collaboration will build on existing infrastructure (local databases and bio-repositories) and will align with the adult European NAFLD Registry ("EPoS", Elucidating Pathways of Steatohepatitis study) to allow long-term follow-up supported by translational studies. Through an international, well-characterised large-scale cohort, we hope to: facilitate multi-centre clinical trials; extend our understanding of the key disease mechanisms of NAFLD; and establish the natural history of paediatric NAFLD.
This description comes directly from the study's public registry record.
Jake P Mann, MRCPCH · 0044124644 · jm2032@cam.ac.uk
Always discuss trial participation with your own doctor first.
| Maastricht UMC | Maastricht, Netherlands | Active Not Recruiting |
| Addenbrooke's Hospital | Cambridge, Cambridgeshire, United Kingdom | Recruiting |
| Birmingham Children's Hospital | Birmingham, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04190849